The landscape of global health diplomacy is shifting rapidly, and Bethany Kozma's recent appointment as the United States' top health envoy is more than just a routine promotion—it's a move that could reshape international health policies in profound ways. But here's where it gets controversial: Kozma’s background and beliefs suggest her leadership might push a very specific ideological agenda, potentially impacting vulnerable populations worldwide.
Bethany Kozma has been named the new head of the Department of Health and Human Services (HHS) Office of Global Affairs, a role that, while not highly visible to the public, carries significant influence over how the U.S. interacts with the world on health issues. This office is often seen as the diplomatic voice of HHS, guiding international health priorities and collaborations. Kozma’s appointment is notable because she lacks a publicly detailed background in global health and has been known for outspoken opinions aligning with conservative and anti-LGBTQ+ viewpoints.
Her activism and public statements reveal a staunch opposition to issues like abortion and gender-affirming care. For example, in a 2016 article on a conservative news platform, she criticized the Obama administration's policies that allowed transgender students to access facilities consistent with their gender identity, warning that such policies could endanger safety by enabling predators. She has also characterized gender fluidity as 'evil' and spoken out against climate change measures, framing them as efforts at 'population control.'
Kozma’s career began in government service during the Bush era, working at the White House Homeland Security Council. During Obama's presidency, she re-emerged as an activist, vocally opposing policies promoting transgender rights in schools. After joining the Trump administration as a senior adviser at USAID, she became even more outspoken, revealing her firm stance against reproductive rights and LGBTQ+ issues.
In 2018, she was recorded in a closed-door UN meeting describing the U.S. as a 'pro-life' nation, emphasizing her belief that 'biological reality' is rooted in 'scientific truth,' which can be a divisive and controversial perspective—especially when debated in the context of human rights and gender diversity.
Her involvement in the Trump administration’s Project 2025—a blueprint proposing substantial reforms to federal agencies—further underscores her ideological stance. She appeared prominently in training videos where she called for rewriting language around climate change and gender issues and fought against 'left-wing pseudoscience.'
Now, as she takes on her new role at HHS, her influence could extend to shaping U.S. health diplomacy at a time when the approach has shifted away from global institutions like the World Health Organization (WHO) toward bilateral treaties with individual nations. These agreements often involve health aid in exchange for policy concessions, and critics worry that Kozma’s views could steer funding and support towards anti-abortion and anti-LGBTQ+ policies.
Specifically, concerns center around the Helms Amendment, a longstanding U.S. policy banning foreign aid from funding abortion services abroad. There's mounting speculation that the current administration might further restrict aid to prevent funding for gender-diversity initiatives, potentially exacerbating health disparities for LGBTQ+ populations and marginalized groups—particularly in regions where health systems are already fragile.
Many advocacy groups and international health experts warn that such policies could lead to increased marginalization, higher infection rates—like HIV among LGBTQ+ communities—and general health inequity. They argue that restricting aid in these ways ignores the complex realities faced by many vulnerable populations and could hinder progress in global health metrics.
So, the big question remains: What will Kozma’s influence mean for the future of U.S. global health diplomacy? Will her ideological convictions lead to policies that prioritize certain moral perspectives over evidence-based health solutions and human rights? And how might this impact populations already at risk?
Are you convinced that her approach will improve or hinder global health efforts? Or do you see potential benefits in her stringent stance? Share your thoughts and join the discussion below—because in a world where health policies affect millions, understanding these shifts is more important than ever.
